GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice

This publication has 38 references indexed in Scilit:

• Fenbufen Pretreatment Potentiates the Anticonvulsant Activity of CPPene and NBQX in DBA/2 Mice
  Journal of Pharmacy and Pharmacology, 1994
• Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models
  Epilepsy Research, 1993
• Glutamate: its role in learning, memory, and the aging brain
  Psychopharmacology, 1993
• The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy
  Drugs, 1992
• Molecular models for recognition and activation at the benzodiazepine receptor: A review
  Life Sciences, 1991
• GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones
  Neuroscience Letters, 1991
• Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-ones
  Journal of Medicinal Chemistry, 1989
• Is tofisopam an atypical anxiolytic?
  Neuroscience & Biobehavioral Reviews, 1986
• A Review of Mouse Mutants as Genetic Models of Epilepsy
  Epilepsia, 1985
• A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.
  Journal of the American Pharmaceutical Association (Scientific ed.), 1957